Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
global-specialty-generic-drugs-market

Global Specialty Generic Drugs Market [By Application (Oncology, Infectious Diseases, Multiple Sclerosis, Hepatitis C, Others); By Route of Administration (Oral, Parenteral, Topical, Injectable, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); By Region]: Market Size & Forecast, 2018 – 2025

Published: Apr 2018
Pages: 100
Format: PDF
Report ID: PM1215
License and Pricing
Buy Now Inquire Before Buying

Report Summary

The global Specialty Generic Drugs Market is estimated to grow at a CAGR of 25.5% between 2018 and 2025. Specialty Generics drugs are the generic forms of pharmaceutical products. These drugs are economical when compared with branded pharmaceuticals. These drugs include complex molecules, biopharmaceuticals, and blood-derived products. Companies are entering into this market to manufacture generic forms of the products by forming new drug formulations as a number of specialty drug molecules are approaching patent in the upcoming years. Additionally, global capacity of conventional or traditional generics drugs market is also forcing companies to seek newer opportunities. Nonetheless, development and commercialization of specialty generics drug are more complex when compared with conventional generics drugs.

Healthcare expenses have increased due to costly pharmaceuticals products, therefore, governments are pressuring pharmaceutical manufacturers to produce cost-effective drugs. Rising prevalence of cancers is one of the major factor enhancing the global specialty generic drugs market growth. According to National Cancer Institute, approximately 16 million cases of cancers are diagnosed every year in the U.S. leading to around half million deaths occur due to various type of cancers. In addition, specialty drugs patent expiries, payer’s pressures to reduce the drug prices, lack of generic drugs to treat complex diseases, and favorable reimbursement policies are other factors anticipated to bolster the demand for specialty generics drugs during the forecast period.

North America Specialty Generic Drugs Market by Type of Technology, 2017 - 2025

North America Specialty Generic Drugs Market by Type of Technology, 2017 - 2025

Inside circle shows data for 2017 and outer circle shows data for 2025

Augmentation in the number of off-patent specialty drugs is factor estimated to propel the significant growth of the specialty generic drugs market. For instance, the patent for Novartis drug Gilenya is estimated to expire in 2019. This drug has made approximately 14% sales growth of Novartis. Such early patent expirations are expected to boost the global market growth. North America is the highest spending region in healthcare, yet, this region recently began cutting healthcare expenditure. The current economic & financial crisis and the existence of a high geriatric population are some of the key reasons for the cost cut in healthcare infrastructure over this region. This creates the need for developing novel, enhanced, and economic methods for production of specialty generics drugs. This factor is further anticipated boost the global specialty generic drugs market in the forecast period.

Segment Analysis

The global specialty generic drugs market is segmented on the basis of application, route of administration, distribution channel, and region. On the basis of application, the global specialty generic drugs market is segmented into Oncology, Infectious diseases, Multiple Sclerosis, Hepatitis C, and Others. Based on the application the oncology segment dominated the global market in 2017. Increased prevalence of cancer, such as melanoma, lung cancer, breast cancer, leukemia, prostate cancer, and colon cancer has directed to rise in demand for generic specialty drugs globally. According to International Agency for Research on Cancer (IARC), 2012, globally approximately 14 million cancer cases were diagnosed, and this number is projected to rise during the coming period. Thus, with the increasing prevalence, there is a huge demand for low-cost generics drugs that are less expensive and highly effective in comparison to branded drugs.

SAMPLE TABLE
North America Specialty Generic Drugs Market, By Route of Administration, 2017 - 2025 
(USD Million)

North America Specialty Generic Drugs Market, By Route of Administration, 2017 - 2025 (USD Million)

On the basis of route of administration, the global market is categorized into Oral, Parenteral, Topical, injectable, and Others. In 2017, the injectable segment estimated for the largest market share majorly owing to benefits, such as long duration of action, immediate dose distribution, and quick absorption.

On the basis of the distribution channel, the global specialty generic drugs market is segmented into Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. In 2017, hospital pharmacy is estimated to share the major market globally as these specialty drugs are highly compound, expensive, and required to be handled very carefully. Thus, these drugs are generally distributed by manufacturers through hospital pharmacies.                   

Regional Analysis

By geography, the global specialty generic drugs market is segmented into five major regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2017, North America dominated the market with the largest share due to favorable healthcare developments by the government and a strapping healthcare infrastructure in this region. Furthermore, healthcare organizations, such as World Health Organizations (WHO), are widely involved in framing policies, such as the National Cancer Control Programs, which are anticipated to expand the growth in this region. The Asia Pacific is anticipated to dominate the global market during the forecast period. The market is driven by a rise in prevalence of chronic diseases as well as high demand for cost-effective generic drugs. In addition, a rise in per head income increases the prospect of usage of specialty generics, and continual upgradation of healthcare infrastructure is recognized to provide the market with global growth opportunities over the forecast period.

Competitive Analysis

Some of the major key players operating in global specialty generic drugs market are Mylan N.V., Teva Pharmaceuticals USA, Inc., Sandoz International GmbH, Mallinckrodt, Akorn Inc., Valeant Pharmaceuticals International Inc., Endo Pharmaceuticals Inc., Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Apotex Corp. among others.

Key questions answered by the report

  • What is the current market size and forecasts of specialty generic drugs
  • What is the market opportunity for specialty generic drugs by application.
  • What is the market opportunity for specialty generic drugs by route of administration.
  • What is the market opportunity for specialty generic drugs by distribution channel.
  • How much is the estimated market for specialty generic drugs in North America and Asia Pacific during the forecast period.
  • What are the companies in this market and how are they classified.
  • What are the available opportunities and who are the top market players in this
  • What are the major drivers and challenges of global Specialty Generic Drugs market
  • Which are the major segments and what traction are they gaining in the market.

Table of Contents

  1. Overview and Scope
    1. Research goal & scope
    2. Research assumptions
    3. Research Methodology
      1. Primary data sources
      2. Secondary data sources
    4. Key take-aways
    5. Stakeholders
  2. Executive Summary
    1. Market Definition
    2. Market Segmentation
  3. Specialty Generic Drugs Market Insights
    1. Specialty Generic Drugs– Industry snapshot
    2. Specialty Generic Drugs -Ecosystem analysis
    3. Specialty Generic Drugs market dynamics
      1. Specialty Generic Drugs– Market Forces
        1. Specialty Generic Drugs Market driver analysis
        2. Specialty Generic Drugs Market restraint/challenges analysis
        3. Specialty Generic Drugs Market opportunity analysis
      2. Industry analysis - Porter's five force
        1. Bargaining power of supplier
        2. Bargaining power of buyer
        3. Threat of substitute
        4. Threat of new entrant
        5. Degree of competition
      3. Specialty Generic Drugs market PEST analysis, 2017
      4. Value Chain Analysis
      5. Specialty Generic Drugs Industry trends
      6. Prevalence of specialty generic drugs  
  4. Specialty Generic Drugs Market Size and Forecast by Application
    1. Key findings
    2. Oncology
      1. Global market estimates and forecasts, 2017 – 2025
    3. Infectious diseases
      1. Global market estimates and forecasts, 2017 – 2025
    4. Multiple Sclerosis
      1. Global market estimates and forecasts, 2017 – 2025
    5. Hepatitis C
      1. Global market estimates and forecasts, 2017 – 2025
    6. Others
      1. Global market estimates and forecasts, 2017 – 2025
  5. Specialty Generic Drugs Market Size and Forecast by Route of Administration
    1. Key findings
    2. Oral
      1. Global market estimates and forecasts, 2017 – 2025
    3. Parenteral
      1. Global market estimates and forecasts, 2017 – 2025
    4. Topical
      1. Global market estimates and forecasts, 2017 – 2025
    5. Injectable
      1. Global market estimates and forecasts, 2017 – 2025
    6. Others
      1. Global market estimates and forecasts, 2017 – 2025
  6. Specialty Generic Drugs Market Size and Forecast by Distribution Channel
    1. Key findings
    2. Retail Pharmacies
      1. Global market estimates and forecasts, 2017 – 2025
    3. Hospital Pharmacies
      1. Global market estimates and forecasts, 2017 – 2025
    4. Online Pharmacies
      1. Global market estimates and forecasts, 2017 – 2025
  7. Specialty Generic Drugs Market Size and Forecast by Regions
    1. Key findings
    2. North America
      1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
      2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
      3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      4. U.S.
        1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
        2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
        3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      5. Canada
        1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
        2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
        3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
    3. Europe
      1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
      2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
      3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      4. Germany
        1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
        2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
        3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      5. UK
        1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
        2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
        3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      6. France
        1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
        2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
        3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
    4. Asia Pacific
      1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
      2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
      3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      4. China
        1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
        2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
        3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      5. India
        1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
        2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
        3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      6. Japan
        1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
        2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
        3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
    5. Latin America
      1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
      2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
      3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      4. Brazil
        1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
        2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
        3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
      5. Mexico
        1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
        2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
        3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
    6. Middle East & Africa
      1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
      2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
      3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
  8. Company Profiles
    1. Mylan N.V.
      1. Overview
      2. Financials
      3. Product Type Benchmarking
      4. Recent Developments
    2. Teva Pharmaceuticals USA, Inc.
      1. Overview
      2. Financials
      3. Product Type Benchmarking
      4. Recent Developments
    3. Sandoz International GmbH
      1. Overview
      2. Financials
      3. Product Type Benchmarking
      4. Recent Developments
    4. Mallinckrodt, Akorn Inc.
      1. Overview
      2. Financials
      3. Product Type Benchmarking
      4. Recent Developments
    5. Akorn Inc.
      1. Overview
      2. Financials
      3. Product Type Benchmarking
      4. Recent Developments
    6. Valeant Pharmaceuticals International Inc.
      1. Overview
      2. Financials
      3. Product Type Benchmarking
      4. Recent Developments
    7. Endo Pharmaceuticals Inc.
      1. Overview
      2. Financials
      3. Product Type Benchmarking
      4. Recent Developments
    8. Pfizer Inc.
      1. Overview
      2. Financials
      3. Product Type Benchmarking
      4. Recent Developments
    9. Sun Pharmaceutical Industries Ltd.
      1. Overview
      2. Financials
      3. Product Type Benchmarking
      4. Recent Developments
    10. Apotex Corp.
      1. Overview
      2. Financials
      3. Product Type Benchmarking
      4. Recent Developments

Report Content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product Type benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecasts from 2017 - 2025
  • Market revenue estimates for Application up to 2025
  • Market revenue estimates for Route of Administration up to 2025
  • Market revenue estimates for Distribution Channel up to 2025
  • Regional market size and forecast for Application up to 2025
  • Regional market size and forecast for Route of Administration up to 2025
  • Regional market size and forecast for Distribution Channel up to 2025
  • Company financials

 

Request For customization

 

By using this form you agree with the storage and handling of your data by this website.

Speak to Analyst

 

By using this form you agree with the storage and handling of your data by this website.

Inquire Before Buying

 

By using this form you agree with the storage and handling of your data by this website.

Request for Sample

By using this form you agree with the storage and handling of your data by this website.